# pleural mesothelioma stages

Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report » Malignant pleural mesothelioma has limited therapeutic options and a poor outcome. Antiangiogenic agents might increase the efficacy of immunotherapy as second-line treatment of advanced-stage malignancies. A patient with stage IIIB pleural mesothelioma… Ncbi.nlm.nih.gov

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ » Incidence of malignant pleural mesothelioma (MPM) is generally higher in males than females and is attributed to historical differences in exposures with world-standardised incidence rates per 100 000 persons of 0.7 and 0.3 in the United States and 1.7 and 0.4 for Europe (for males and females, respectively). Incidence is highest in countries with greatest previous asbestos use such as the Netherlands, UK and Australia.1 Due to a lag time of ∼40 years between exposure and presentation, alongside relatively recent usage bans, incidence continues to rise in many countries. Annalsofoncology.org

Mesothelioma Life Expectancy: What Factors Affect Your Prognosis? » How does each stage affect your mesothelioma prognosis? Learn about the life expectancy of patients at each stage of mesothelioma. Asbestos.com